ProPhase Labs Statistics

Total Valuation

ProPhase Labs has a market cap or net worth of $6.00 million. The enterprise value is $13.28 million.

Market Cap	6.00M
Enterprise Value	13.28M

Important Dates

The last earnings date was Wednesday, November 19, 2025, before market open.

Earnings Date	Nov 19, 2025
Ex-Dividend Date	n/a

Share Statistics

ProPhase Labs has 46.18 million shares outstanding. The number of shares has increased by 94.71% in one year.

Current Share Class	46.18M
Shares Outstanding	46.18M
Shares Change (YoY)	+94.71%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	7.22%
Owned by Institutions (%)	6.56%
Float	42.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.93
Forward PS	0.61
PB Ratio	0.79
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.14, with a Debt / Equity ratio of 1.12.

Current Ratio	0.14
Quick Ratio	0.07
Debt / Equity	1.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.28

Financial Efficiency

Return on equity (ROE) is -220.34% and return on invested capital (ROIC) is -44.99%.

Return on Equity (ROE)	-220.34%
Return on Assets (ROA)	-23.50%
Return on Invested Capital (ROIC)	-44.99%
Return on Capital Employed (ROCE)	-284.31%
Revenue Per Employee	$52,656
Profits Per Employee	-$434,417
Employee Count	96
Asset Turnover	0.06
Inventory Turnover	1.92

Taxes

In the past 12 months, ProPhase Labs has paid $15.18 million in taxes.

Income Tax	15.18M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.69% in the last 52 weeks. The beta is -0.64, so ProPhase Labs's price volatility has been lower than the market average.

Beta (5Y)	-0.64
52-Week Price Change	-81.69%
50-Day Moving Average	0.35
200-Day Moving Average	0.37
Relative Strength Index (RSI)	25.01
Average Volume (20 Days)	3,172,866

Short Selling Information

The latest short interest is 89,622, so 0.19% of the outstanding shares have been sold short.

Short Interest	89,622
Short Previous Month	246,172
Short % of Shares Out	0.19%
Short % of Float	0.21%
Short Ratio (days to cover)	0.07

Income Statement

In the last 12 months, ProPhase Labs had revenue of $5.06 million and -$41.70 million in losses. Loss per share was -$1.16.

Revenue	5.06M
Gross Profit	987,000
Operating Income	-29.61M
Pretax Income	-34.38M
Net Income	-41.70M
EBITDA	-24.22M
EBIT	-29.61M
Loss Per Share	-$1.16

Full Income Statement

Balance Sheet

The company has $405,000 in cash and $7.68 million in debt, giving a net cash position of -$7.28 million or -$0.16 per share.

Cash & Cash Equivalents	405,000
Total Debt	7.68M
Net Cash	-7.28M
Net Cash Per Share	-$0.16
Equity (Book Value)	6.86M
Book Value Per Share	0.17
Working Capital	-47.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$10.63 million and capital expenditures -$40,000, giving a free cash flow of -$10.67 million.

Operating Cash Flow	-10.63M
Capital Expenditures	-40,000
Free Cash Flow	-10.67M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross Margin	19.53%
Operating Margin	-585.78%
Pretax Margin	-680.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ProPhase Labs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.71%
Shareholder Yield	-94.71%
Earnings Yield	-694.69%
FCF Yield	-177.77%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 23, 1997. It was a forward split with a ratio of 2:1.

Last Split Date	Jan 23, 1997
Split Type	Forward
Split Ratio	2:1

Scores

ProPhase Labs has an Altman Z-Score of -3.5 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.5
Piotroski F-Score	1